Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19 : a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Citation
STOP-COVID19 Investigators 2022 , ' Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19 : a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial ' , The Lancet. Respiratory medicine , vol. 10 , no. 12 , pp. 1119-1128 . https://doi.org/10.1016/S2213-2600(22)00261-2
Rights
Under a Creative Commons license https://creativecommons.org/licenses/by/4.0/